Cardiac Imaging in Carcinoid Heart DiseaseShow others and affiliations
2021 (English)In: JACC Cardiovascular Imaging, ISSN 1936-878X, E-ISSN 1876-7591, Vol. 14, no 11, p. 2240-2253Article in journal (Refereed) Published
Abstract [en]
Carcinoid disease is caused by neuroendocrine tumors, most often located in the gut, and leads in approximately 20% of cases to specific, severe heart disease, most prominently affecting right-sided valves. If cardiac disease occurs, it determines the patient's prognosis more than local growth of the tumor. Surgical treatment of carcinoid-induced valve disease has been found to improve survival in observational studies. Cardiac imaging is crucial for both diagnosis and management of carcinoid heart disease; in the past, imaging was accomplished largely by echocardiography, but more recently, imaging for carcinoid heart disease has increasingly become multimodal and warrants awareness of the particular diagnostic challenges of this disease. This paper reviews the pathophysiology and manifestations of carcinoid heart disease in light of the different imaging modalities.
Place, publisher, year, edition, pages
American College of Cardiology, 2021. Vol. 14, no 11, p. 2240-2253
Keywords [en]
carcinoid disease, multimodality imaging, pulmonary regurgitation, tricuspid regurgitation, valvular heart disease
National Category
Cardiology and Cardiovascular Disease Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:uu:diva-456092DOI: 10.1016/j.jcmg.2020.12.030ISI: 000729265100002PubMedID: 33865761OAI: oai:DiVA.org:uu-456092DiVA, id: diva2:1603236
2021-10-142021-10-142025-02-10Bibliographically approved